Difference between revisions of "Invasive breast cancer"
Jump to navigation
Jump to search
| Line 114: | Line 114: | ||
| Familial breast and ovarian cancer<ref name=omim113705>{{OMIM|113705}}</ref> | | Familial breast and ovarian cancer<ref name=omim113705>{{OMIM|113705}}</ref> | ||
| male breast, ovarian, prostate, pancreas, fallopian tube | | male breast, ovarian, prostate, pancreas, fallopian tube | ||
| younger | | younger individuals vis-à-vis BRCA2 | ||
|- | |- | ||
| BRCA2 | | BRCA2 | ||
| Familial breast and ovarian cancer 2<ref name=omim600185>{{OMIM|600185}}</ref> | | Familial breast and ovarian cancer 2<ref name=omim600185>{{OMIM|600185}}</ref> | ||
| male breast, ovarian, prostate, pancreas, stomach, melanoma, gallbladder, bile duct, pharynx | | male breast, ovarian, prostate, pancreas, stomach, melanoma, gallbladder, bile duct, pharynx | ||
| older | | older individuals vis-à-vis BRCA1 | ||
|- | |- | ||
| TP53 (p53) | | TP53 (p53) | ||
| Line 134: | Line 134: | ||
| [[Peutz-Jeghers syndrome]] | | [[Peutz-Jeghers syndrome]] | ||
| breast cancer, GI cancer, [[Sertoli cell tumour]], [[Granulosa cell tumour]], [[SCTAT]] | | breast cancer, GI cancer, [[Sertoli cell tumour]], [[Granulosa cell tumour]], [[SCTAT]] | ||
| characteristic GI | | characteristic GI [[hamartoma]]s, mucocutaneous pigmentation | ||
|- | |- | ||
| PTEN | | PTEN | ||